Peak Group (600668.SH): Englitazene has been approved for listing application of chemical raw material pharmaceuticals.

Zhijun Finance and Economics APP News, Peak Group (600668.SH) announced that recently, its wholly-owned subsidiary Zhejiang Peak Pharmaceutical Co., Ltd.("Peak Pharmaceutical") received the "Approval Notice for the Listing Application of Chemical Raw Material Drug Engliqin" (Notification No.: 2025YS00624) from the National Medical Products Administration.